Lawrence Otto Klein

CRSP

Lawrence Otto Klein serves as director, officer: Chief Executive Officer at CRISPR Therapeutics AG (CRSP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

9 trades

$21.85M

Net Position

Net Seller

$21.85M

Companies Traded

ORKA, CRSP

Active Period

Mar 2021 – Sep 2026

9 total trades

Most Recent

Sell ORKA

Sep 15, 2026 · $234.7K

Lawrence Otto Klein's Insider Trading at CRISPR Therapeutics AG (CRSP)

Buys

0 · $0.00

Sells

5 · $14.53M

Total Shares Bought

Total Shares Sold

120,645

CRSP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 10, 2022	Sell	3,112	$61.98	$192.9K
Dec 3, 2021	Sell	11,185	$69.17	$773.7K
Sep 10, 2021	Sell	4,207	$117.86	$495.8K
Mar 23, 2021	Sell	100,000	$128.05	$12.81M
Mar 10, 2021	Sell	2,141	$124.15	$265.8K

Lawrence Otto Klein's Insider Trading at Oruka Therapeutics, Inc. (ORKA)

Buys

0 · $0.00

Sells

4 · $7.31M

Total Shares Bought

Total Shares Sold

80,910

ORKA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 15, 2026	Sell	2,452	$95.71	$234.7K	923,128
Sep 1, 2026	Sell	75,000	$91.83	$6.89M	993,976
Jun 15, 2026	Sell	1,729	$69.69	$120.5K	925,580
Mar 17, 2026	Sell	1,729	$41.30	$71.4K	927,309